Tag: Glioma clinical trial

Home / Glioma clinical trial

Categories

Epigenetic Agent-Based Immunotherapy Shows Promise in Diffuse Midline Glioma

Diffuse midline glioma (DMG), specifically the H3K27-mutated subtype, is among the most malignant and lethal types of pediatric-type brain tumors. Marked by poor prognosis and ineffectiveness to tradi...
glioma-clinical-trial

Scan the code